Kent Morris, MD
Clinical Cardiac Electrophysiology · Louisville, KYNPI 1215128178
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $141,238 of the $187,150 with a category attached, or 75.5%. Atricure, Inc. accounts for 60.1% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $55,414, 4.1 times the $13,422 reported in 2019. Among clinical cardiac electrophysiology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 531 payments — averaging $352.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$112K
- Medtronic$34K
- Boston Scientific$28K
- Biosense Webster, Inc.$3K
- E.r. Squibb & Sons, L.L.C.$3K
- Pfizer$3K
- plus $3K from 12 others
Across 104 payments — averaging $3839.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$142K
- Biosense Webster, Inc.$135K
- Medtronic$62K
- Atricure, Inc.$46K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$14K
What the payments were for
- Consulting fees$141,23875%
- Speaking & faculty fees$7,5004%
- Travel & lodging$16,1309%
- Food & beverage$22,28212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 109 | $112,463 |
| Medtronic(2 entities) | 267 | $34,309 |
| Boston Scientific | 80 | $27,969 |
| Biosense Webster, Inc. | 38 | $3,278 |
| E.r. Squibb & Sons, L.L.C. | 2 | $2,894 |
| Pfizer | 5 | $2,817 |
| Medical Device Business Services, Inc. | 2 | $2,063 |
| Abbott | 4 | $377 |
| Heartflow, Inc. | 2 | $268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $169 |
| Inari Medical, Inc. | 1 | $147 |
| Abiomed | 2 | $134 |
| AstraZeneca | 2 | $66 |
| Novartis | 4 | $66 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Edwards Lifesciences | 1 | $28 |
| Johnson & Johnson | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$93,710
- ATRICLIP LAA EXCLUSION SYSTEM$20,575
- GENERAL - THERAPIES$13,508
- SYNERGY ABLATION SYSTEM$6,284
- Carto 3$5,946
- LARIAT RS$5,713
- ELIQUIS$5,643
- WATCHMAN Access System$1,389
- Micra$857
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$707
- ISOLATOR SURGICAL ABLATION SYSTEM$450
- DISSECTOR$450
- COBALT DR MRI SURESCAN$428
- PACEART SYSTEM ECG MODULE$300
- FLOWTRIEVER CATHETER, S$295
- EPI-SENSE GUIDED COAGULATION SYS$288
- Farapulse$287
- COREVALVE EVOLUT R$282
- Rhythmia Mapping System$271
- AZURE XT DR MRI SURESCAN$269
How this compares
$187,150 in reported general payments places this provider in the 90th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 247 | $268,064 |
| XareltoRivaroxaban | 46 | $59,733 |
| Flecainide Acetate | 103 | $4,249 |
| Metoprolol Succinate | 257 | $3,366 |
| Dofetilide | 27 | $2,678 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 17 | $2,098 |
| Amiodarone Hcl | 97 | $1,077 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $783 |
| Digoxin | 22 | $687 |
| Warfarin Sodium | 89 | $549 |
| Carvedilol | 67 | $434 |
| Furosemide | 50 | $397 |
| ClopidogrelClopidogrel Bisulfate | 27 | $299 |
| SotalolSotalol Hcl | 17 | $251 |
| Metoprolol Tartrate | 41 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,817 | $268,064247 claims |
| Johnson & JohnsonXarelto | $25 | $59,73346 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Louisville
- Rajdeep GaitondeLouisville$404K
- Jeffrey StidamLouisville$196K
- Kevin ParrottLouisville$60K
- Megan GruberLouisville$46K
- Nachiket ApteLouisville$44K
- Abhishek BoseLouisville$39K
- Michael YuLouisville$32K
- Christopher JohnsrudeLouisville$23K
- Hassan KhanLouisville$22K
- Kevin ThomasLouisville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.